Microdialysis monitoring of porcine liver metabolism during warm ischemia with arterial and portal clamping.
Early detection of vascular complications following liver surgery is crucial. In the present study, intrahepatic microdialysis was used for continuous monitoring of porcine liver metabolism during occlusion of either the portal vein or the hepatic artery. Our aim was to assess whether microdialysis can be used to detect impaired vascular inflow by metabolic changes in the liver. Changes in metabolite concentrations in the hepatic interstitium were taken as markers for metabolic changes. After laparotomy, microdialysis catheters were introduced directly into the liver, enabling repeated measurements of local metabolism. Glucose, lactate, pyruvate, and glycerol were analyzed at bedside every 20 minutes, and the lactate/pyruvate ratio was calculated. In the arterial clamping group, the glucose, lactate, glycerol, and lactate/pyruvate ratio significantly increased during the 2-hour vessel occlusion and returned to baseline levels during the 3-hour reperfusion. In the portal occlusion group and in the control group, the measured metabolites were stable throughout the experiment. Our findings show that liver metabolism, as reflected by changes in the concentrations of glucose, lactate, and glycerol and in the lactate/pyruvate ratio, is markedly affected by occlusion of the hepatic artery. Surprisingly, portal occlusion resulted in no major metabolic changes. In conclusion, the microdialysis technique can detect and monitor arterial vascular complications of liver surgery, whereas potential metabolic changes in the liver induced by portal occlusion were not seen in the current study. Microdialysis may thus be suitable for use in liver surgery to monitor intrahepatic metabolic changes.
Ungerstedt
Johan
J
Department of Physiology and Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden. johan.ungerstedt@telia.com
Nowak
Greg
G
Ungerstedt
Urban
U
Ericzon
Bo-Göran
BG
D000758:Anesthesia / Q000379:methods; D000818:Animals; D003250:Constriction; D005260:Female; D005947:Glucose / Q000378:metabolism; D006221:Halothane / Q000494:pharmacology; D006499:Hepatic Artery / Q000502:physiology*; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000601:surgery; D008102:Liver Circulation; D017551:Microdialysis / Q000379:methods*; D008874:Midazolam / Q000494:pharmacology; D008991:Monitoring, Physiologic / Q000379:methods; D011169:Portal Vein / Q000502:physiology*; D019289:Pyruvic Acid / Q000378:metabolism; D013552:Swine
D019344:Lactic Acid; D019289:Pyruvic Acid; D005947:Glucose; D008874:Midazolam; D006221:Halothane